Cefuroxime Axetil & Potassium Clavulanate Tablets IP – Broad-spectrum power with enhanced protection.
DEXTUM CL: The Composition of Cefuroxime Axetil 500 mg + Potassium Clavulanate IP 125 mg is designed to combat bacterial infections, especially those caused by β-lactamase-producing organisms. Cefuroxime Axetil is a broad-spectrum cephalosporin antibiotic effective against Gram-positive and Gram-negative bacteria. Potassium Clavulanate is a β-lactamase inhibitor that enhances Cefuroxime’s effectiveness against resistant bacterial strains.
Recommended By Specialists:
✅General Physicians: Treating the disease associated with broad-spectrum coverage in common bacterial infections is preferred.
✅Pulmonologists: It is preferred to treat the disease associated with respiratory tract infections, such as bronchitis and pneumonia.
✅Urologists: It is prefer to treat the disease associated with urinary tract infections (UTIs) caused by resistant bacteria.
Key Benefits of Cefuroxime Axetil & Potassium Clavulanate Tablets IP – DEXTUM CL:
✅Potent Dual Action – Cefuroxime Axetil, a 2nd-generation cephalosporin, offers broad-spectrum antibacterial activity, while Potassium Clavulanate inhibits β-lactamase enzymes, enhancing efficacy against resistant bacteria.
✅Superior β-lactamase Protection – Clavulanate protects Cefuroxime from bacterial resistance mechanisms, ensuring extended coverage against β-lactamase-producing pathogens.
✅Effective in Recurrent Infections—It demonstrates high clinical success rates in treating complicated and recurrent respiratory and urinary tract infections.
INDICATIONS:
✅Upper & Lower Respiratory Tract Infections (e.g., pharyngitis, tonsillitis, bronchitis)
✅Urinary Tract Infections (UTIs)
✅Skin & Soft Tissue Infections
✅Acute Otitis Media